{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:34:58Z","timestamp":1793676898495,"version":"4.5.1"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To explore suzetrigine, a novel voltage-gated sodium channel inhibitor for pain management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Suzetrigine is a first-in-class, oral peripheral sodium channel inhibitor that selectively targets Nav1.8 channels and was recently approved for the treatment of moderate to severe acute pain. In phase 3 trials, suzetrigine demonstrated superior efficacy to placebo in reducing pain intensity after surgery and was generally well tolerated. Studies for nonacute pain indications, including diabetic peripheral neuropathy and painful lumbosacral radiculopathy, are in progress.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Suzetrigine represents an advancement in pain management as a nonopioid alternative for pain with potentially lower abuse risk and potentially fewer serious adverse effects when compared to opioids. While initial results are promising, further research is needed to establish its long-term safety and efficacy for various painful conditions. Research will continue in the area of analgesics that selectivity inhibit peripheral sodium channels.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ajhp\/zxaf219","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T11:51:08Z","timestamp":1755258668000},"page":"245-253","source":"Crossref","is-referenced-by-count":5,"title":["Suzetrigine: A novel selective sodium channel inhibitor for pain"],"prefix":"10.1093","volume":"83","author":[{"given":"Denise","family":"Courtney","sequence":"first","affiliation":[{"name":"Veterans Health Administration Southeast Network , Decatur, GA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudheer","family":"Potru","sequence":"additional","affiliation":[{"name":"Atlanta VA Health Care System , Decatur, GA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Mathew","sequence":"additional","affiliation":[{"name":"VA Capitol Health Care Network , Washington, DC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"key":"2026030907325848600_zxaf219-B1","doi-asserted-by":"publisher","first-page":"379","DOI":"10.15585\/mmwr.mm7215a1","article-title":"Chronic pain among adults\u2014United States, 2019\u20132021","volume":"72","author":"Rikard","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"518","key":"2026030907325848600_zxaf219-B2","doi-asserted-by":"publisher","first-page":"CS355235","DOI":"10.15620\/cdc\/169630","article-title":"Chronic pain and high-impact chronic pain in U.S. adults, 2023","author":"Lucas","year":"2024","journal-title":"NCHS Data Brief"},{"issue":"3","key":"2026030907325848600_zxaf219-B3","doi-asserted-by":"publisher","first-page":"e1075","DOI":"10.1097\/PR9.0000000000001075","article-title":"Prevalence of postoperative pain after hospital discharge: systematic review and meta-analysis","volume":"8","author":"Park","year":"2023","journal-title":"Pain Rep"},{"issue":"3","key":"2026030907325848600_zxaf219-B4","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1097\/MS9.0000000000001724","article-title":"Acute postoperative pain prevalence and intensity in the first 72 hour in Dessie Comprehensive Specialized Hospital, Ethiopia: a prospective single center observational study","volume":"86","author":"Timerga","year":"2024","journal-title":"Ann Med Surg (Lond)"},{"key":"2026030907325848600_zxaf219-B5","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.2147\/IJGM.S419239","article-title":"Pharmacological methods of pain management: narrative review of medication used","volume":"16","author":"Alorfi","year":"2023","journal-title":"Int J Gen Med"},{"issue":"2, suppl","key":"2026030907325848600_zxaf219-B6","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.36076\/ppj.2008\/11\/S105","article-title":"Opioid complications and side effects","volume":"11","author":"Benyamin","year":"2008","journal-title":"Pain Physician"},{"key":"2026030907325848600_zxaf219-B7","doi-asserted-by":"publisher","first-page":"721357","DOI":"10.3389\/fpain.2021.721357","article-title":"Opioids and chronic pain: an analytic review of the clinical evidence","volume":"2","author":"Nadeau","year":"2021","journal-title":"Front Pain Res (Lausanne)"},{"key":"2026030907325848600_zxaf219-B8","author":"Horn"},{"issue":"12","key":"2026030907325848600_zxaf219-B9","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1080\/17581869.2024.2442292","article-title":"Novel non-opioid analgesics in pain management","volume":"14","author":"Pulskamp","year":"2024","journal-title":"Pain Manag"},{"issue":"pt 3","key":"2026030907325848600_zxaf219-B10","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/j.1469-7793.1998.647bp.x","article-title":"Structure and function of voltage-gated sodium channels","volume":"508","author":"Marban","year":"1998","journal-title":"J Physiol"},{"issue":"18","key":"2026030907325848600_zxaf219-B11","doi-asserted-by":"publisher","first-page":"7093","DOI":"10.1021\/jm501981g","article-title":"Voltage-gated sodium channels: structure, function, pharmacology, and clinical indications","volume":"58","author":"de Lera Ruiz","year":"2015","journal-title":"J Med Chem"},{"key":"2026030907325848600_zxaf219-B12","author":"Grider"},{"issue":"6","key":"2026030907325848600_zxaf219-B13","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1080\/19336950.2017.1380758","article-title":"Distribution and function of voltage-gated sodium channels in the nervous system","volume":"11","author":"Wang","year":"2017","journal-title":"Channels (Austin)"},{"issue":"6","key":"2026030907325848600_zxaf219-B14","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1080\/19336950.2015.1079674","article-title":"Voltage gated sodium channels as drug discovery targets","volume":"9","author":"Bagal","year":"2015","journal-title":"Channels (Austin)"},{"issue":"7","key":"2026030907325848600_zxaf219-B15","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s40263-017-0441-0","article-title":"Sodium channel blockers in the treatment of epilepsy","volume":"31","author":"Brodie","year":"2017","journal-title":"CNS Drugs"},{"issue":"4","key":"2026030907325848600_zxaf219-B16","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1085\/jgp.201611668","article-title":"Mechanism of sodium channel block by local anesthetics, antiarrhythmics, and anticonvulsants","volume":"149","author":"Tikhonov","year":"2017","journal-title":"J Gen Physiol"},{"issue":"9","key":"2026030907325848600_zxaf219-B17","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1093\/brain\/aws225","article-title":"Neurological perspectives on voltage-gated sodium channels","volume":"135","author":"Eijkelkamp","year":"2012","journal-title":"Brain"},{"issue":"5","key":"2026030907325848600_zxaf219-B18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa2209870","article-title":"Selective inhibition of NaV1.8 with VX-548 for acute pain","volume":"389","author":"Jones","year":"2023","journal-title":"N Engl J Med"},{"key":"2026030907325848600_zxaf219-B19","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-024-00697-0","article-title":"Pharmacology and mechanism of action of suzetrigine, a potent and selective NaV1.8 pain signal inhibitor for the treatment of moderate to severe pain","author":"Osteen","year":"8, 2025","journal-title":"Pain Ther"},{"key":"2026030907325848600_zxaf219-B20","author":"Journavx"},{"key":"2026030907325848600_zxaf219-B21","author":"Bertoch"},{"key":"2026030907325848600_zxaf219-B22","author":"McCoun"},{"key":"2026030907325848600_zxaf219-B23","author":"Vertex Pharmaceuticals Incorporated"},{"key":"2026030907325848600_zxaf219-B24","author":"Vertex Pharmaceuticals Incorporated"},{"key":"2026030907325848600_zxaf219-B25","author":"Vertex Pharmaceuticals Incorporated"},{"key":"2026030907325848600_zxaf219-B26","author":"Rind"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxaf219\/64074628\/zxaf219.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/83\/6\/245\/64074628\/zxaf219.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/83\/6\/245\/64074628\/zxaf219.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T11:33:01Z","timestamp":1773055981000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/83\/6\/245\/8237156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,8,18]]},"published-print":{"date-parts":[[2026,3,9]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxaf219","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3,15]]},"published":{"date-parts":[[2025,8,18]]}}}